Chemical-structure (Chemical Structure)
Topiramate Tablet, Film Coated
Product Images NDC 71335-0487
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1jpg (Figure 1)
This is a graph that shows the cumulative rates for the time it takes to have the first seizure. The graph plots two groups of participants, one that received Topiramate 50mg/day (N=234) and another that received Topiramate 400mg/day (N=236). The data point out that the group that received Topiramate 400mg/day has a lower cumulative rate of seizures, meaning that the medication is potentially more efficient at preventing seizures. The graph includes a p-value of 0.0002, indicating that the difference between the two groups is statistically significant. The X-axis shows the time in days, and the Y-axis shows the cumulative rate of seizures, ranging from 0 to 0.5.*
Figure-2 (Figure 2)
Label (Lbl713350487)
This is a medication package for Topiramate 50mg tablets, used for the treatment of seizures, migraine headaches, and weight loss. It is manufactured by Sun Pharmaceutical Industries Ltd. The tablets are yellow, round-shaped, and have the marking "S;710" imprinted on them. The package contains 30 tablets and should be stored at room temperature between 20° - 25°C (68°-77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
